Methylamine

Methylamine

SCHEMBL6028022

CN.O=[N+]([O-])c1ccc(Br)nc1Br

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.38
CYP3A4 P08684 3/20 0.38
TXNRD1 Q16881 5/20 0.38
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 2/20 0.37
CTSB P07858 2/20 0.36
CTSH P09668 1/20 0.36
HSD17B10 Q99714 1/20 0.35
CYP1A2 P05177 1/20 0.35
RECQL P46063 1/20 0.35
HTT P42858 1/20 0.35
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
GFER P55789 1/20 0.35
PAX8 Q06710 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29518366 0.94 TDP1 (0.38) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL40986 0.94 TDP1 (0.38) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL2034272 0.78 TDP1 (0.42) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL1582439 0.78 TDP1 (0.42) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL3040192 0.78 CTSB (0.51) TSHRCYP3A4TDP1ALDH1A1MAPT
SCHEMBL1128565 0.78 TSHR (0.44) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL30660529 0.78 TXNRD1 (0.56) TXNRD1MAPTHTTS1PR4S1PR1
SCHEMBL3062790 0.78 TXNRD1 (0.56) TXNRD1MAPTHTTS1PR4S1PR1
Bromide SCHEMBL6299103 0.77 TDP1 (0.41) TSHRCYP3A4TXNRD1TDP1ALDH1A1
SCHEMBL29154637 0.76 GPR35 (0.43) TSHRCYP3A4TDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060194782-A1 Pharmacologically active imidazo[4,5-c] pyridines ALTANA PHARMA AG (DE) 2006-08-31 US disclosed
EP-1670795-A1 PHARMACOLOGICALLY ACTIVE IMIDAZO 4,5-C PYRIDINES ALTANA Pharma AG (DE) 2006-06-21 EP disclosed
WO-2005026164-A1 PHARMACOLOGICALLY ACTIVE IMIDAZO[4,5-C]PYRIDINES ALTANA PHARMA AG (DE) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194782-A1 Pharmacologically active imidazo[4,5-c] pyridines GIPR, VIP, PGC TSHR 1113/4885CYP3A4 29/4885TXNRD1 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.